Heart Disease and Diabetes

AHA Report: Obesity Responsible for Half of New US Diabetes Cases

February 13, 2021

A recent study from Northwestern University suggests 30-53% of all new diabetes cases in the United States were directly attributable to obesity.

Medicare Patients Less Likely to be Prescribed GLP-1RAs, SGLT2 Inhibitors than Commercially Insured

February 10, 2021

Data from an analysis of nearly 400k older patients suggests Medicare Advantage beneficiaries were less likely than their counterparts with commercial insurance to be prescribed newer glucose-lowering agents such as GLP-1RAs and SGLT2 inhibitors.

Health Coach-Based Primary Care Programs Linked to Reduced Cardiovascular Risk

February 09, 2021

An intervention implementing the use of a health coach in a primary care setting based on the 2013 AHA/ACC/Task Force for the Management of Overweight and Obesity in Adults guidelines was associated with greater weight loss and improvements in blood glucose levels and HDL-C compared to usual care.

HbA1c Swings After Initial Diabetes Diagnosis Helps Predict CVD Risk

February 06, 2021

An analysis of nearly 30k patients from the LEAD study suggests increased HbA1c variability within the first 2 years of a diabetes diagnosis was associated with a 30-59% increase in risk of incident cardiovascular disease.

Gestational Diabetes Raises Long-Term Heart Attack Risk, Regardless of Post-Birth Glycemic Control

February 03, 2021

An analysis of data obtained from the CARDIA study offers insight into the subsequent cardiovascular risks associated with gestational diabetes and how glucose control after pregnancy impacts this apparent increase risk.

Diabetes, Insulin Resistance Help Predict Premature Coronary Heart Disease in Women

January 23, 2021

An analysis of data and blood samples from more than 28k women provides insight into the predictive value of more than 50 biomarkers for predicting risk of premature coronary heart disease in aging women.

Lockdowns Led to Weight Gain, Increases in Stress But No Changes in Glycemic Control Among Diabetics

January 16, 2021

Data from questionnaires given to type 1 and type 2 diabetes patients from an outpatient clinic is providing insight into how the COVID-19 pandemic has impacted diabetes management.

Reducing Cardiovascular Autonomic Neuropathy Risk with Intensive Blood Pressure, Glucose Control

December 21, 2020

A retrospective analysis of more than 7k patients from the ACCORD trial suggests intensive blood pressure and intensive blood glucose control could reduce the risk of cardiovascular autonomic neuropathy in diabetics.

Bariatric Surgery in Obese Teens Provides Greater CVD Risk Reduction Than Standard Care

December 10, 2020

A comparison of data from Teen-LABS and TODAY offer insight into the effects of medical therapy alone vs bariatric surgery in obese teens with type 2 diabetes.

A Resident's Perspective: SGLT2 Inhibitors for Primary Prevention

December 08, 2020

A resident from Penn State Hershey Medical Center offers his perspective on the potential of the SGLT2 inhibitor class to transform the treatment of diabetes and cardiovascular disease among patients with diabetes.